Multi-Manager U.S. Small Cap Equity Fund ASND Holdings History
Multi-Manager U.S. Small Cap Equity Fund's Ascendis Pharma AS Holding Summary
As of 2025-01-31, Goldman Sachs Trust II held 58,290.00 shares of Ascendis Pharma AS(ASND), totaling $7.62 Mil. This investment constitutes 1.36% of their stock portfolio, and Goldman Sachs Trust II now holds 0.1% of the outstanding Ascendis Pharma AS(ASND) stock.
The initial trade took place in 2020Q4. And since then Multi-Manager U.S. Small Cap Equity Fund has made 13 purchases of ASND, at an average price of $114.66, for a total of 106,897.00 shares. In addition, there have been 4 sales at an average price of $129.36 for 48,607.00 shares. Based on historical transaction data and ASND's current price of $175.78, Multi-Manager U.S. Small Cap Equity Fund's estimated gain on his ASND holdings is $4.28 Mil, reflecting a 34.90% gain to date.
Multi-Manager U.S. Small Cap Equity Fund ASND ($175.78) Holding Chart
Multi-Manager U.S. Small Cap Equity Fund ASND ($175.78) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
